Science is moving fast. In the 19 years since ALK+ lung cancer was discovered, targeted therapies have extended survival from mere months to 5 years, 10 years, and even longer for some patients. But there is no cure, not all patients have durable responses to available treatments, and new options are essential. CK, who was diagnosed in February 2025, dreams of a curative vaccine that could turn around the lives of people with ALK+ cancer—about 90% of whom are diagnosed at stage 4. ALK Positive directly supports research that could make CK’s dream of a cure—one shared by hundreds of thousands worldwide—a reality. Donate today https://secure.qgiv.com/event/moredreams/donate/ & learn more about our vaccine efforts with Break Through Cancer https://alkpositive.org/blog/break-through-cancer-and-alk-positive-inc-team-up-to-conquer-alk-positive-lung-cancer-with-a-2-million-multi-year-research-partnership/. #MoreResearchMoreDreams